PARROTTE DIANNE M 4
4 · COGNEX CORP · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Cognex (CGNX) Director Dianne Parrotte Converts 8,324 RSUs
What Happened
- Dianne M. Parrotte, a director of Cognex Corporation (CGNX), had 8,324 restricted stock units (RSUs) converted into 8,324 shares on 2026-02-18 and the same 8,324 shares were reported as disposed the same day. The Form 4 reports an acquisition price of $0.00 and a disposition price of $0.00 (no cash consideration reported). This filing reflects the settlement/conversion of an equity award rather than an open‑market purchase.
Key Details
- Transaction date: 2026-02-18. Filing date (Form 4): 2026-02-19 (filed timely).
- Reported prices: Acquired 8,324 shares @ $0.00; Disposed 8,324 shares @ $0.00.
- Shares owned after transaction: Not specified in the provided filing details.
- Footnotes: F1 — each restricted stock unit represents a contingent right to one share. F2 — the RSUs vest 100% on the first anniversary of the grant date (noted as February 18, 2025 in the filing).
- Transaction code: M (exercise or conversion of a derivative).
Context
- This was a conversion/settlement of RSUs (derivative-to-common-stock conversion). The filing shows the shares were disposed at conversion (per the Form 4); the Form 4 does not state proceeds or the reason for the disposition (e.g., sale, tax withholding, or transfer). Such RSU vesting/settlement transactions by directors are typically routine award settlements rather than directional bets on the stock.
Insider Transaction Report
Form 4
COGNEX CORPCGNX
PARROTTE DIANNE M
Director
Transactions
- Exercise/Conversion
Common Stock
2026-02-18+8,324→ 30,518 total - Exercise/Conversion
Restricted Stock Unit
[F1][F2]2026-02-18−8,324→ 0 totalExercise: $0.00From: 2026-02-18Exp: 2026-02-18→ Common Stock (8,324 underlying)
Holdings
- 7,500
Non-Qualified Stock Option (right to buy)
Exercise: $45.06From: 2019-05-02Exp: 2028-05-02→ Common Stock (7,500 underlying) - 18,400
Non-Qualified Stock Option (right to buy)
Exercise: $50.94From: 2021-02-18Exp: 2030-02-18→ Common Stock (18,400 underlying) - 18,100
Non-Qualified Stock Option (right to buy)
Exercise: $51.49From: 2020-02-19Exp: 2029-02-19→ Common Stock (18,100 underlying) - 2,913
Restricted Stock Unit
Exercise: $0.00From: 2024-02-21Exp: 2026-02-21→ Common Stock (2,913 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
- [F2]The restricted stock units vest 100% on the first anniversary of the grant date (February 18, 2025).
Signature
Dianne M. Parrotte|2026-02-19